Clinical Trials Browser

Lymphoma, B-Cell, Marginal Zone × copanlisib × 90 days × Clear all

NCT03474744 2026-05-06

Copanlisib and Rituximab in Marginal Zone Lymphoma Patients

Phase 2 Active not recruiting

Neoplasms, Lymphoma, B-Cell, Marginal Zone